Specify a stock or a cryptocurrency in the search bar to get a summary
Shenzhen YHLO Biotech Co. Ltd. A
688575Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers automatic chemiluminescence immunoassay analyzers, chemiluminescent immunoassay analyzers, and iModule automatic immunoassay pipelines; and automatic immunofluorescence staining systems, automatic immunofluorescence analysis systems, automatic western blotting analyzers, auto automatic western blot analyzers, and automatic western blotting instruments. It also provides UNION new generation immune analyzers; dry fluorescence immunoassay analyzers, vision automatic dynamic ESR analyzers, and vision dynamic ESR analyzers; and automated sample processing systems and intelligent laboratory information systems, as well as antigen detection and test kits. Shenzhen YHLO Biotech Co., Ltd. was founded in 2008 and is headquartered in Shenzhen, China. Address: Building 1, Baolong, 2nd Road, Shenzhen, China, 518116
Analytics
WallStreet Target Price
189.56 CNYP/E ratio
37.14Dividend Yield
1.5 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688575
Dividend Analytics 688575
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
47 %Dividend History 688575
Stock Valuation 688575
Financials 688575
Results | 2019 | Dynamics |